Neuroendocrine Tumor of the Lung
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate [Phase 1]
Phase 1 study evaluating radiopharmaceutical 177Lu-DTPA-SC16.56 in neuroendocrine carcinomas of the lung and prostate; the trial is not yet …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Risk Factors for Neuroendocrine Neoplasms
A recruiting clinical trial investigating risk factors for neuroendocrine neoplasms of the lung and gastrointestinal tract.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors [Phase 2]
A Phase 2 study is evaluating daily 5 mg versus 10 mg everolimus in patients with neuroendocrine tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Everolimus TDM to Predict Long Term Toxicity
A clinical trial evaluates whether therapeutic drug monitoring of everolimus can predict long-term toxicity in cancer patients.